KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Novavax (NVAX) over the last 8 years, with Q3 2025 value amounting to 5.03%.

  • Novavax's Return on Invested Capital fell 56700.0% to 5.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.03%, marking a year-over-year decrease of 56700.0%. This contributed to the annual value of 0.41% for FY2024, which is 4300.0% down from last year.
  • Per Novavax's latest filing, its Return on Invested Capital stood at 5.03% for Q3 2025, which was down 56700.0% from 18.12% recorded in Q2 2025.
  • Novavax's 5-year Return on Invested Capital high stood at 9.06% for Q1 2022, and its period low was 31.28% during Q4 2021.
  • Its 5-year average for Return on Invested Capital is 1.7%, with a median of 0.51% in 2024.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first surged by 323600bps in 2022, then crashed by -185800bps in 2025.
  • Quarter analysis of 5 years shows Novavax's Return on Invested Capital stood at 31.28% in 2021, then skyrocketed by 103bps to 1.08% in 2022, then dropped by -25bps to 0.82% in 2023, then plummeted by -40bps to 0.49% in 2024, then tumbled by -1138bps to 5.03% in 2025.
  • Its Return on Invested Capital stands at 5.03% for Q3 2025, versus 18.12% for Q2 2025 and 1.26% for Q1 2025.